About 95,000 results
Any time
Open links in new tab
- Studies of Adriamycin Ifosfamide
AIM (Adriamycin + Ifos + Mesna) Sarcoma | ChemoExperts
AIM (Adriamycin® + Ifosfamide + Mesna) is a Chemotherapy Regimen for Sarcoma. How does AIM work? Each of the medications in AIM are designed to kill and slow growth of cancer cells. A – Adriamycin (Doxorubicin) I - Ifosfamide (Ifex) M - Mesna (Mesnex) Goals of therapy: AIM is given to shrink tumors and alleviate symptoms of sarcoma.Chemotherapy for Soft Tissue Sarcomas - American Cancer Society
Doxorubicin and ifosfamide | Cancer information - Cancer …
Doxorubicin alone versus intensified doxorubicin plus ifosfamide …
Treatment protocols for soft tissue and bone sarcoma
Transitioning adriamycin ifosfamide mesna (AIM) chemotherapy in …
High-dose ifosfamide plus adriamycin in the treatment of adult …
Chemotherapy for soft tissue sarcoma - Ratan - 2016
Jul 19, 2016 · Despite 2 recent drug approvals, doxorubicin and ifosfamide remain the most effective chemotherapy drugs available for the treatment of majority of these tumors. Optimal dosing and administration influence …
Frontiers | Doxorubicin/Adriamycin Monotherapy or …
Nov 21, 2021 · Background: Doxorubicin/Adriamycin (ADM) alone or combined with ifosfamide (IFO) (AI) is available for previously untreated advanced soft tissue sarcoma (ASTS). However, the clinical choice between them remains …
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus …
Related searches for Adriamycin Ifosfamide